Invega Sustenna Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Alerts
• Clinical Trials
• Forums

Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia Patients
Condition:   Schizophrenia Patients Intervention:   Drug: Paliperidone Palmitate Sponsors:   Luye Pharma Group Ltd.;   Alliance for Clinical Trials in Oncology;   Evolution Research Group Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2020 Category: Research Source Type: clinical trials